Risk reduction in the intensive care unit.
Hansen
D B
DB
D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007362:Intensive Care Units; D012306:Risk; D013921:Thrombocytopenia / Q000139:chemically induced*; D020246:Venous Thrombosis / Q000188:drug therapy*
D006495:Heparin, Low-Molecular-Weight